Related Experiment Videos
When to Start Levodopa Therapy for Parkinson's Disease
Susan Bressman1, Rachel Saunders-Pullman1
1From the Icahn School of Medicine at Mt. Sinai, New York.
The New England Journal of Medicine
|January 24, 2019
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Essential genetic testing in movement disorders - results from a Delphi study.
Parkinsonism & related disorders·2026
Integrated Stress Response Signatures Drive Monocyte Dysfunction in GBA1- and LRRK2-Linked Parkinson's Disease.
medRxiv : the preprint server for health sciences·2025
Segmental and Multifocal Isolated Dystonias: Similarities and Differences.
Movement disorders clinical practice·2025
More Than Rapid Eye Movement Sleep Behavior Disorder: Sleep Differences in Parkinson's Disease LRRK2 and GBA Genotypes.
Journal of sleep medicine·2025
Fibromyalgia.
The New England journal of medicine·2026
Health Care-Associated Infections in U.S. Hospitals, 2023 versus 2015.
The New England journal of medicine·2026
Extended Dual Antiplatelet Therapy for Multivessel Coronary Artery Disease.
The New England journal of medicine·2026
Continuous or Fixed-Duration Maintenance Therapy in Multiple Myeloma.
The New England journal of medicine·2026
Andes Virus - A Clinical Review.
The New England journal of medicine·2026
Platelet-Activating Anti-Platelet Factor 4 Disorders.
The New England journal of medicine·2026
Roles and impacts of pharmacists in attention-deficit hyperactivity disorder services: a scoping review.
International journal of clinical pharmacy·2026
Pharmacists in OPAT: a systematic review and meta-analysis.
The Journal of antimicrobial chemotherapy·2026
Association Between Depressive Symptoms and Self-Reported Ongoing Medication Use Among Pharmacy Students: A Cross-Sectional Study.
Healthcare (Basel, Switzerland)·2026